Form D/A — Revalesio Corp
0001552377-25-000005 · filed Dec 16, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $40,300,000
- Reported amount sold
- $38,877,508
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Revalesio Corp
- CIK
- 1552377
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1202 E. D ST
TACOMA, Washington 98421 - Phone
- 253 922 2600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
GREG ARCHAMBEAU · Executive OfficerTACOMA, Washington Find on LinkedIn ↗
-
CHRIS FIBIGER · DirectorTACOMA, Washington Find on LinkedIn ↗
-
MATT IRELAND · DirectorTACOMA, Washington Find on LinkedIn ↗
-
JAMES NORDSTROM · DirectorTACOMA, Washington Find on LinkedIn ↗
-
ERIC RUSSELL · DirectorTACOMA, Washington Find on LinkedIn ↗
-
JANE TAYLOR · DirectorTACOMA, Washington Find on LinkedIn ↗
-
BERT VAN DEN BERGH · DirectorTACOMA, Washington Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗